{
    "paper_id": "0187705c2a09525d5cb71ec594b82e668255fcaf",
    "metadata": {
        "title": "Entrada del virus de la inmunodeficiencia humana en las c\u00e9lulas: mecanismos y posibilidades terap\u00e9uticas",
        "authors": [
            {
                "first": "Ver\u00f3nica",
                "middle": [],
                "last": "Briz",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Servicio de Enfermedades Infecciosas. Hospital Carlos III. Madrid",
                    "location": {
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "Eva",
                "middle": [],
                "last": "Poveda",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Servicio de Enfermedades Infecciosas. Hospital Carlos III. Madrid",
                    "location": {
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            },
            {
                "first": "Vicente",
                "middle": [],
                "last": "Soriano",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Servicio de Enfermedades Infecciosas. Hospital Carlos III. Madrid",
                    "location": {
                        "country": "Espa\u00f1a"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "La entrada del virus de la inmunodeficiencia humana (VIH) en la c\u00e9lula es la primera etapa del ciclo de replicaci\u00f3n viral y una diana clave en la exploraci\u00f3n de nuevos antirretrovirales. El mejor conocimiento de los mecanismos que se suceden con la entrada del VIH en las c\u00e9lulas que infecta ha permitido el desarrollo de mol\u00e9culas que bloquean cada una de las etapas de la entrada v\u00edrica: uni\u00f3n de gp120 al receptor CD4; uni\u00f3n de gp120 a los correceptores de quimiocinas CCR5 y CXCR4, y fusi\u00f3n de las membranas viral y celular. Los inhibidores de la entrada del VIH son la \u00faltima generaci\u00f3n de antirretrovirales, de los cuales la enfuvirtida, un inhibidor de la fusi\u00f3n, ha sido el primero en comercializarse. Varios m\u00e1s se encuentran actualmente en fases avanzadas de desarrollo cl\u00ednico y es de esperar que pronto contribuir\u00e1n a mejorar el arsenal terap\u00e9utico frente al VIH.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Palabras clave: VIH. Entrada viral. Inhibidores de la entrada. Enfuvirtida.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "HIV entry into the cells -mechanisms and therapeutic possibilities",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "in the viral replication cycle, which has been explored as a new therapeutic target. A better knowledge of the mechanisms involved in the entry process has led to the development of agents, which may inhibit each of the different steps of the viral entry process: attachment of the gp120 to the CD4 cell receptor; binding of the gp120 to CCR5 or CXCR4 coreceptors; and the fusion of viral and cell membranes. Entry inhibitors are the latest family of antiretroviral compounds, being enfuvirtide, a fusion inhibitor, the first approved. Several other entry inhibitors are currently in clinical development and hopefully soon will be part of the therapeutic armamentarium against HIV.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "La introducci\u00f3n del tratamiento antirretroviral de gran actividad para el tratamiento de la infecci\u00f3n por el virus de inmunodeficiencia humana (VIH) en la \u00faltima d\u00e9cada ha mejorado notablemente el pron\u00f3stico de vida de los individuos infectados 1 . Sin embargo, su \u00e9xito a menudo es de tiempo limitado, debido principalmente a la aparici\u00f3n de mutaciones en los virus que confieren resistencia a los f\u00e1rmacos antirretrovirales. El n\u00famero de personas infectadas con virus resistentes va en aumento 2,3 , lo que obliga al continuo desarrollo de nuevos f\u00e1rmacos dise\u00f1ados para inhibir la replicaci\u00f3n de virus resistentes. Una estrategia eficaz en este sentido es utilizar compuestos con dianas terap\u00e9uticas diferentes de las actuales. En teor\u00eda, la entrada viral se considera uno de los puntos m\u00e1s atractivos para nuevas intervenciones terap\u00e9uticas.",
            "cite_spans": [
                {
                    "start": 245,
                    "end": 246,
                    "text": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "El VIH puede entrar en las c\u00e9lulas por fusi\u00f3n o endocitosis. La utilizaci\u00f3n de una u otra v\u00eda tiene diferentes consecuencias en la infectividad. La entrada mediante fusi\u00f3n de las membranas viral y celular conduce a una infecci\u00f3n productiva 4, 5 . Por el contrario, la endocitosis culmina en una inactivaci\u00f3n del viri\u00f3n en los endosomas acidificados o en una degradaci\u00f3n en los lisosomas celulares. Sin embargo, estudios recientes in vitro indican que la endocitosis tambi\u00e9n podr\u00eda permitir la integraci\u00f3n del genoma del virus en las c\u00e9lulas y la expresi\u00f3n temprana de genes virales 6 . En algunos tipos celulares, como las c\u00e9lulas dendr\u00edticas, la endocitosis tambi\u00e9n puede participar en la diseminaci\u00f3n del VIH, debido al papel de estas c\u00e9lulas en la presentaci\u00f3n del ant\u00edgeno a las c\u00e9lulas T 7 . Por tanto, aunque menos eficiente que mediante fusi\u00f3n, actualmente debe aceptarse que la endocitosis tambi\u00e9n puede facilitar la expansi\u00f3n de la infecci\u00f3n por el VIH. Durante el proceso de entrada, el VIH se une a la superficie celular a trav\u00e9s del reconocimiento de receptores celulares espec\u00edficos. La uni\u00f3n a estos receptores dar\u00e1 lugar a una serie de cambios conformacionales en la prote\u00edna de la envoltura viral que finalmente permitir\u00e1n que las membranas viral y celular se fusionen. A continuaci\u00f3n, sigue la penetraci\u00f3n de la c\u00e1pside viral en el citosol. En los \u00faltimos a\u00f1os se han investigado mol\u00e9culas capaces de inhibir el proceso de entrada del VIH y actualmente representan una nueva familia de f\u00e1rmacos para el tratamiento de la infecci\u00f3n por el VIH. Se trata de los inhibidores de la entrada, de los cuales el primero que se aprob\u00f3 fue la enfuvirtida, un inhibidor de la fusi\u00f3n 8, 9 . En la actualidad se encuentra en fase de desarrollo cl\u00ednico un amplio n\u00famero de mol\u00e9culas que pueden bloquear el proceso de entrada del VIH en las c\u00e9lulas. Si finalmente se confirma su efectividad y si su perfil de efectos secundarios es aceptable, pronto pasar\u00e1n a formar parte del arsenal terap\u00e9utico frente al VIH. A continuaci\u00f3n se revisa en detalle las distintas etapas del proceso de entrada del VIH en las c\u00e9lulas y los mecanismos de acci\u00f3n de los f\u00e1rmacos dise\u00f1ados para bloquear ese primer paso del ciclo de replicaci\u00f3n viral.",
            "cite_spans": [
                {
                    "start": 240,
                    "end": 242,
                    "text": "4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 243,
                    "end": 244,
                    "text": "5",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 582,
                    "end": 583,
                    "text": "6",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 1688,
                    "end": 1690,
                    "text": "8,",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1691,
                    "end": 1692,
                    "text": "9",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "El VIH es un virus con envoltura, y es la prote\u00edna de la envoltura la que media su entrada en la c\u00e9lula diana. La glucoprote\u00edna de la envoltura del VIH es una prote\u00edna integral de membrana, que se genera como una poliprote\u00edna precursora de 160 kDa, denominada gp160. En el aparato de Golgi, mediante la acci\u00f3n de una proteasa celular, se genera la envoltura madura, formada por la uni\u00f3n no covalente de 2 subunidades asociadas: las glucoprote\u00ednas gp120 y gp41 10 . La envoltura madura est\u00e1 presente en la membrana viral formando tr\u00edmeros. No se conoce bien la secuencia de cambios conformacionales que llevan a la fusi\u00f3n de las membranas viral y celular.",
            "cite_spans": [
                {
                    "start": 460,
                    "end": 462,
                    "text": "10",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [],
            "section": "Entrada del VIH en la c\u00e9lula"
        },
        {
            "text": "Los estudios realizados hasta el momento han permitido proponer un modelo en que la clave es la uni\u00f3n de gp120 al receptor CD4. Esta interacci\u00f3n desencadena una sucesi\u00f3n de cambios conformacionales que finalmente permiten la fusi\u00f3n entre las membranas viral y celular. El proceso de entrada comienza cuando gp120 se une al receptor celular CD4. Esta uni\u00f3n provoca un cambio conformacional en la envoltura v\u00edrica que permite la interacci\u00f3n de gp120 con los receptores de quimiocinas CCR5 y CXCR4, que se encuentran en la superficie de la c\u00e9lula diana. Este cambio conformacional se traduce en una liberaci\u00f3n est\u00e9rica de gp41. Como consecuencia, se produce otro cambio conformacional por el cual el complejo de la prote\u00edna de la envoltura pasa de un estado no fus\u00f3geno a un estado fus\u00f3geno. Esto se debe en gran parte a la exposici\u00f3n del dominio hidrof\u00f3bico N-terminal de gp41, que se inserta a trav\u00e9s del p\u00e9ptido de fusi\u00f3n en la membrana plasm\u00e1tica de la c\u00e9lula diana, lo que permite la fusi\u00f3n de las membranas viral y celular. A esto sigue la entrada de la c\u00e1pside viral en el citosol 11, 12 .",
            "cite_spans": [
                {
                    "start": 1085,
                    "end": 1088,
                    "text": "11,",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1089,
                    "end": 1091,
                    "text": "12",
                    "ref_id": "BIBREF11"
                }
            ],
            "ref_spans": [],
            "section": "Entrada del VIH en la c\u00e9lula"
        },
        {
            "text": "En 1984 se identific\u00f3 la mol\u00e9cula CD4 como el principal receptor del VIH en las c\u00e9lulas [13] [14] [15] . La interacci\u00f3n de gp120 con el receptor CD4 es el primer paso del proceso de entrada viral. La prote\u00edna viral gp120 est\u00e1 formada por 2 dominios, uno interno y otro externo, unidos por un puente de l\u00e1minas beta. En dichos dominios se localizan 5 regiones constantes (C1 a C5) y 5 regiones variables (V1 a V5) (figs. 1 y 2). Las regiones V1/V2, V3 y C4 son las m\u00e1s importantes en la entrada viral. Los puentes disulfuro 16, 17 formados entre ambos domi-nios dar\u00e1n lugar a la estructura tridimensional de gp120, que es funcional. Uno de estos dominios ser\u00e1 el encargado del reconocimiento del receptor CD4 y de su uni\u00f3n. El sitio de interacci\u00f3n entre CD4 y gp120 se sit\u00faa en la cavidad formada entre ambos dominios de gp120 y est\u00e1 constituido por elementos derivados de las regiones C3 y C4 18, 19 . Esta cavidad est\u00e1 conservada en las diferentes variantes del VIH y no contiene sitios de glucosilaci\u00f3n 20, 21 . El sitio de interacci\u00f3n de CD4 y gp120 est\u00e1 resguardado, protegido y bien conservado estructuralmente. Estas caracter\u00edsticas han llevado a considerarlo una diana terap\u00e9utica, con la b\u00fasqueda de agentes que puedan unirse espec\u00edficamente y bloquear esta etapa inicial de la infecci\u00f3n viral.",
            "cite_spans": [
                {
                    "start": 88,
                    "end": 92,
                    "text": "[13]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 93,
                    "end": 97,
                    "text": "[14]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 98,
                    "end": 102,
                    "text": "[15]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 523,
                    "end": 526,
                    "text": "16,",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 527,
                    "end": 529,
                    "text": "17",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 893,
                    "end": 896,
                    "text": "18,",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 897,
                    "end": 899,
                    "text": "19",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 1005,
                    "end": 1008,
                    "text": "20,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1009,
                    "end": 1011,
                    "text": "21",
                    "ref_id": "BIBREF20"
                }
            ],
            "ref_spans": [],
            "section": "Uni\u00f3n gp120-CD4"
        },
        {
            "text": "La interacci\u00f3n entre CD4 y gp120 es mayoritariamente de tipo electrost\u00e1tico. El sitio de uni\u00f3n al receptor CD4 en gp120 tiene carga negativa y atrae la carga positiva del receptor. Adem\u00e1s, hay fuerzas de Van der Waals y puentes de hidr\u00f3geno que ayudan a estabilizar la interacci\u00f3n CD4-gp120. La fenilalanina, situada en la posici\u00f3n 43 de la mol\u00e9cula CD4, es el \u00fanico residuo que se une a esta cavidad. Este residuo es de gran importancia en la uni\u00f3n, ya que se ha estimado que es la causa de un 23% de la interacci\u00f3n entre el receptor CD4 y gp120 20, 21 . Como consecuencia de esta uni\u00f3n, el n\u00facleo conservado de gp120 sufre cambios conformacionales que hacen que pase de un estado flexible a otro r\u00edgido, lo cual permite la interacci\u00f3n posterior con los receptores de quimiocinas 22 .",
            "cite_spans": [
                {
                    "start": 547,
                    "end": 550,
                    "text": "20,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 551,
                    "end": 553,
                    "text": "21",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 781,
                    "end": 783,
                    "text": "22",
                    "ref_id": "BIBREF21"
                }
            ],
            "ref_spans": [],
            "section": "Mecanismo de la uni\u00f3n gp120-CD4"
        },
        {
            "text": "Hay un gran n\u00famero de mol\u00e9culas capaces de inhibir la uni\u00f3n gp120-CD4. Poseen distintas estructura y funci\u00f3n. Entre ellas destacan PRO-542, una mol\u00e9cula que imita al receptor CD4, y TNX-355, que simula anticuerpos dirigidos frente al receptor. PRO-542 es una prote\u00edna recombinante soluble que incorpora 4 copias de dominios de uni\u00f3n de CD4, con una estructura similar a los anticuerpos (CD4-inmunoglobulina G2) 23 . Es uno de los inhibidores de la uni\u00f3n gp120-CD4 en fase m\u00e1s avanzada de desarrollo cl\u00ednico. De los estudios en fase I se concluy\u00f3 que PRO-542 era bien tolerado por los pacientes, al tiempo que no se identificaron dosis limitantes de toxicidad 24 . En pacientes en fases avanzadas de la enfermedad (carga viral mayor de 100.000 copias/ml y cifra reducida de linfocitos CD4+) se observ\u00f3 una reducci\u00f3n de la viremia mayor de 0,5 log 10 entre las semanas 4 y 6 de tratamiento 25 . Finalmente, en estudios que han combinado PRO-542 y enfuvirtida se ha observado una sinergia en la inhibici\u00f3n de la replicaci\u00f3n del VIH 26 . El mayor inconveniente de este inhibidor es que debe administrarse por v\u00eda parenteral. TNX-355 es otro inhibidor de la uni\u00f3n CD4-gp120 que simula un anticuerpo dirigido frente al receptor CD4. Por tanto, compite con gp120 por la uni\u00f3n a CD4. Estudios in vitro llevados a cabo con el fin de mostrar el sitio de uni\u00f3n de dicho f\u00e1rmaco a gp120 concluyeron que se une en un lugar distinto del CD4 y previene los cambios conformacionales que siguen a la uni\u00f3n gp120-CD4 requeridos para la entrada del VIH en la c\u00e9lula 27 . En la actualidad est\u00e1 en fase II de desarrollo cl\u00ednico. La actividad antiviral de CADA, un inhibidor espec\u00edfico del receptor CD4, est\u00e1 relacionada con su capacidad de disminuir la expresi\u00f3n de dicho receptor 28 . CADA no interacciona directamente con el receptor CD4 y/o gp120. Su acci\u00f3n es postransduccional, no transcripcional 29 . La acci\u00f3n del inhibidor BMS-806 consiste en unirse a la glucoprote\u00edna gp120 de la envoltura del virus y bloquear los cambios conformacionales inducidos en dicha glucoprote\u00edna cuando gp120 se une al receptor CD4 20 . La uni\u00f3n entre BMS-806 y gp120 es espec\u00edfica y reversible, e independiente de los correceptores 30, 31 .",
            "cite_spans": [
                {
                    "start": 411,
                    "end": 413,
                    "text": "23",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 659,
                    "end": 661,
                    "text": "24",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 888,
                    "end": 890,
                    "text": "25",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1029,
                    "end": 1031,
                    "text": "26",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 1547,
                    "end": 1549,
                    "text": "27",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 1760,
                    "end": 1762,
                    "text": "28",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 1881,
                    "end": 1883,
                    "text": "29",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 2097,
                    "end": 2099,
                    "text": "20",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 2198,
                    "end": 2201,
                    "text": "30,",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 2202,
                    "end": 2204,
                    "text": "31",
                    "ref_id": "BIBREF33"
                }
            ],
            "ref_spans": [],
            "section": "F\u00e1rmacos inhibidores de la uni\u00f3n gp120-CD4"
        },
        {
            "text": "Uni\u00f3n de gp120 a los receptores de quimiocinas CCR5 y CXCR4",
            "cite_spans": [],
            "ref_spans": [],
            "section": "F\u00e1rmacos inhibidores de la uni\u00f3n gp120-CD4"
        },
        {
            "text": "Hasta mediados de la d\u00e9cada de los a\u00f1os ochenta se pensaba que la entrada del VIH en las c\u00e9lulas requer\u00eda \u00fanicamente la uni\u00f3n del virus al receptor celular CD4. Diversos estudios posteriores demostraron que miembros de la familia de los receptores de quimiocinas, principalmente CCR5 y CXCR4, son igualmente necesarios para el proceso de entrada del VIH en la c\u00e9lulas [32] [33] [34] . En los \u00faltimos a\u00f1os se ha relacionado el tropismo viral por los receptores de quimiocinas CCR5 y CXCR4 con el estadio de la infecci\u00f3n y con la progresi\u00f3n de la enfermedad. Durante la primoinfecci\u00f3n y en la fase cr\u00f3nica de la infecci\u00f3n por el VIH se detectan \u00fanicamente variantes R5, mientras que en los estadios m\u00e1s avanzados de la enfermedad se observa la presencia de cepas X4, que se asocian con una mayor virulencia y una progresi\u00f3n m\u00e1s r\u00e1pida a sida 35 .",
            "cite_spans": [
                {
                    "start": 368,
                    "end": 372,
                    "text": "[32]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 373,
                    "end": 377,
                    "text": "[33]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 378,
                    "end": 382,
                    "text": "[34]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 840,
                    "end": 842,
                    "text": "35",
                    "ref_id": "BIBREF38"
                }
            ],
            "ref_spans": [],
            "section": "F\u00e1rmacos inhibidores de la uni\u00f3n gp120-CD4"
        },
        {
            "text": "Los correceptores CXCR4 y CCR5 pertenecen a la superfamilia de receptores de 7 dominios transmembrana acoplados a la prote\u00edna G. Presentan una estructura \u03b1-h\u00e9lice de 4 dominios transmembrana: 3 bucles extracelulares y un dominio N-terminal. La uni\u00f3n del complejo CD4-gp120 a los correceptores se produce a trav\u00e9s de la regi\u00f3n V3 de gp120, aunque hay otras regiones de \u00e9sta que tambi\u00e9n participan en esta interacci\u00f3n. En particular, el brazo de la regi\u00f3n V3 de gp120, junto con residuos del dominio conservado C4, se encarga de la uni\u00f3n de gp120 al dominio N-terminal de CCR5, mientras que tanto la corona como el brazo de V3 participan en la uni\u00f3n de gp120 a la superficie de CCR5 36 . En el caso de CXCR4, es la regi\u00f3n V3 de gp120 la que interacciona directamente con CXCR4, con independencia de las regiones V1/V2 de gp120 37 . El mapeo de la regi\u00f3n de uni\u00f3n de gp120 al receptor de quimiocinas indica que, para el virus R5, el dominio N-terminal y el segundo bucle extracelular de CCR5 son esenciales para el reconocimiento y la actividad como correceptor 38, 39 , mientras que para las cepas X4 el lugar cr\u00edtico es el segundo bucle extracelular (ECL2). La modificaci\u00f3n por mutag\u00e9nesis dirigida del dominio N-terminal de CXCR4 demuestra que algunos virus requieren un N-terminal completo, mientras otros no se afectan por la eliminaci\u00f3n de la mayor parte de la secuencia N-terminal 40 .",
            "cite_spans": [
                {
                    "start": 681,
                    "end": 683,
                    "text": "36",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 1059,
                    "end": 1062,
                    "text": "38,",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 1063,
                    "end": 1065,
                    "text": "39",
                    "ref_id": "BIBREF42"
                }
            ],
            "ref_spans": [],
            "section": "Mecanismo de uni\u00f3n de gp120 a CCR5 y CXCR4"
        },
        {
            "text": "La gp120 est\u00e1 originalmente en un estado cerrado sobre la envoltura viral, de modo que el sitio de uni\u00f3n del correceptor queda oculto por los bucles V1/V2 y V3. Una vez que el receptor CD4 se une a gp120, tiene lugar una serie de cambios conformacionales y el sitio de uni\u00f3n del correceptor queda expuesto. En el caso del correceptor CCR5, en ausencia del inhibidor, su dominio N-terminal interacciona con los residuos expuestos en la l\u00e1mina puente y el brazo de V3, mientras que los residuos del ECL2 de CCR5 interaccionan con la corona de V3. En presencia del inhibidor, ECL2 experimenta cambios conformacionales de modo que no puede interaccionar con la corona de V3. De esta forma se inhibe la entrada viral 41 ( fig. 3 ). Aunque el modelo anterior se desarroll\u00f3 para los antagonistas AD101 y SCH-C, se piensa que es el mecanismo general de acci\u00f3n de todas estas peque\u00f1as mol\u00e9culas inhibidoras de CCR5. Aunque muchos antagonistas de CCR5 (TAK-779, SCH-C, SCH-D UK-427,857 y GW873140) se unen a un sitio com\u00fan de CCR5, el efecto que producen en el correceptor es diferente, ya que son compuestos estructuralmente distintos 42 . Sin embargo, el resultado final es el mismo. Los sitios de uni\u00f3n de los antagonistas de CXCR4 a este correceptor se localizan en residuos presentes en ECL2 [43] [44] [45] . Debido a que CXCR4 posee una superficie con gran carga negativa 46 , se piensa que las interacciones que tienen lugar entre el bucle V3 de gp120 y CXCR4 son de tipo electrost\u00e1tico 47 .",
            "cite_spans": [
                {
                    "start": 1126,
                    "end": 1128,
                    "text": "42",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 1287,
                    "end": 1291,
                    "text": "[43]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 1292,
                    "end": 1296,
                    "text": "[44]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 1297,
                    "end": 1301,
                    "text": "[45]",
                    "ref_id": null
                },
                {
                    "start": 1368,
                    "end": 1370,
                    "text": "46",
                    "ref_id": "BIBREF49"
                }
            ],
            "ref_spans": [
                {
                    "start": 717,
                    "end": 723,
                    "text": "fig. 3",
                    "ref_id": null
                }
            ],
            "section": "Mecanismo de acci\u00f3n de los antagonistas de CCR5 y CXCR4"
        },
        {
            "text": "Los inhibidores de los correceptores se pueden dividir en tres grupos seg\u00fan su tama\u00f1o. TAK-779, SCH-C, UK-427857 y GW873140). Todas ellas se intercalan en el dominio de uni\u00f3n de la membrana celular. Los antagonistas de CCR5 son mol\u00e9culas que tras su uni\u00f3n al correceptor inhiben su funci\u00f3n bloqueando la uni\u00f3n de gp120 a CCR5. Las quimiocinas son prote\u00ednas que presentan una actividad inhibitoria frente al VIH. Estos antagonistas se presentan como alternativa a las quimiocinas. TAK-779 es la primera mol\u00e9cula no pept\u00eddica que bloquea la replicaci\u00f3n in vitro de cepas R5 mediante su interacci\u00f3n con CCR5 48 . El sitio de uni\u00f3n est\u00e1 localizado en una cavidad de CCR5 que forman las regiones transmembrana 1, 2, 3 y 7 del receptor 49 . Debido a que no puede administrarse por v\u00eda oral y a que ocasiona reacciones locales importantes en el lugar de inyecci\u00f3n, se desestim\u00f3 su desarrollo y se investigaron mol\u00e9culas pr\u00f3ximas que llevaron a la identificaci\u00f3n de un nuevo antagonista, TAK-220. \u00c9ste posee gran capacidad para bloquear la replicaci\u00f3n de cepas R5 y, a diferencia de TAK-779, es de administraci\u00f3n oral 50 . Est\u00e1n en marcha los estudios en fase II. TAK-652 es un nuevo antagonista de Takeda Chemical Industries. Se administra por v\u00eda oral, y estudios in vivo han confirmado su elevada potencia frente al VIH, adem\u00e1s de una buena tolerancia en los pacientes 51 . Por otro lado, presenta actividad antiviral frente a diferentes subtipos del VIH. PRO-140 es un antagonista del correceptor CCR5 que act\u00faa como un anticuerpo monoclonal dirigido frente a CCR5 bloqueando la uni\u00f3n de gp120 al correceptor. Adem\u00e1s de inhibir aislados del subtipo B, tambi\u00e9n es activo frente a los subtipos A, C, E y F 52 . En la actualidad, est\u00e1 en fases I-II de desarrollo cl\u00ednico. SCH-C (SCH-351,125) presenta gran actividad in vitro frente a cepas R5. Sus an\u00e1logos SCH-D (SCH-417,857) y AD101 (SCH-350,581) han sido escogidos para su desarrollo cl\u00ednico. Los 3 antagonistas son de administraci\u00f3n oral. Los residuos que interaccionan con CCR5 se encuentran situados en una cavidad transmembrana, de modo que, cuando se unen a CCR5, interrumpen la conformaci\u00f3n del dominio extracelular y, por tanto, inhiben la uni\u00f3n de gp120 a CCR5 41 . Actualmente se est\u00e1n llevando a cabo ensayos cl\u00ednicos en fase II con el antagonista SCH-D.",
            "cite_spans": [
                {
                    "start": 730,
                    "end": 732,
                    "text": "49",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 1110,
                    "end": 1112,
                    "text": "50",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 1364,
                    "end": 1366,
                    "text": "51",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 2215,
                    "end": 2217,
                    "text": "41",
                    "ref_id": "BIBREF44"
                }
            ],
            "ref_spans": [],
            "section": "F\u00e1rmacos antagonistas de CCR5"
        },
        {
            "text": "UK-427,857 (maravirok) se encuentra en fase III de desarrollo cl\u00ednico. Los resultados obtenidos en la fase II fueron muy prometedores. Los pacientes examinados experimentaron una notable reducci\u00f3n de la carga viral (1,42 log de media) 53 . Por otro lado, se observ\u00f3 una actividad antiviral sostenida mucho m\u00e1s all\u00e1 de la esperada atendiendo a la vida media del f\u00e1rmaco, ya que la carga viral permaneci\u00f3 suprimida durante al menos 10 d\u00edas tras finalizar el tratamiento [53] [54] [55] . El lugar de uni\u00f3n de maravirok al correceptor se localiza en la cavidad transmembrana de CCR5, entre las h\u00e9lices 2, 3, 6 y 7, y es distinto del descrito para TAK-779 56 . Por \u00faltimo, GW873140 posee una gran potencia in vitro e in vivo, y se han descrito descensos de carga viral de hasta 2 log 57,58 . Actualmente est\u00e1n en marcha ensayos cl\u00ednicos en fase II con este medicamento. A diferencia del resto de los antagonistas de CCR5, GW873140 interacciona directamente con ECL2 en vez de hacerlo en la cavidad transmembrana 59 . Debido a que induce una conformaci\u00f3n en el receptor diferente de la producida por otros antagonistas, se ha postulado que podr\u00eda presentar un perfil de resistencia diferente del resto de antagonistas de CCR5 42 . Recientemente se han observado algunos casos de toxicidad hep\u00e1tica asociados al uso del f\u00e1rmaco y se han interrumpido algunos de los estudios cl\u00ednicos en espera de que se aclare el mecanismo de esta hepatotoxicidad.",
            "cite_spans": [
                {
                    "start": 235,
                    "end": 237,
                    "text": "53",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 468,
                    "end": 472,
                    "text": "[53]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 473,
                    "end": 477,
                    "text": "[54]",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 478,
                    "end": 482,
                    "text": "[55]",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 651,
                    "end": 653,
                    "text": "56",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 1007,
                    "end": 1009,
                    "text": "59",
                    "ref_id": "BIBREF69"
                }
            ],
            "ref_spans": [],
            "section": "F\u00e1rmacos antagonistas de CCR5"
        },
        {
            "text": "La potente actividad antiviral que AMD3100 muestra frente a cepas X4 se ha confirmado en diversos estudios in vitro e in vivo 44, 60 . Sin embargo, la compa\u00f1\u00eda farmac\u00e9utica AnorMED interrumpi\u00f3 su producci\u00f3n en el a\u00f1o 2001 debido a que, durante un ensayo cl\u00ednico en fase Ia/IIb, dos de los pacientes tratados presentaron alteraciones del ritmo card\u00edaco. Por otro lado, AMD3100 no present\u00f3 la eficacia esperada a las dosis evaluadas en este ensayo cl\u00ednico. Con posterioridad se han identificado compuestos derivados de la mol\u00e9cula AMD3100 que tambi\u00e9n muestran actividad frente al VIH. Uno de ellos es AMD070. Se administra por v\u00eda oral y es bien tolerado 61 . En marzo de 2005 AnorMED anunci\u00f3 el inicio de estudios de fase Ib/IIa con AMD070, en el que se examinan con m\u00e1s detalle la actividad antiviral y la seguridad del f\u00e1rmaco. KRH-1636 es otro antagonista de CXCR4 que presenta una actividad antiviral similar a AMD3100. Estudios llevados a cabo en ratas mostraron que el f\u00e1rmaco se absorbe en el duodeno, de modo que, como AMD070, podr\u00eda administrarse por v\u00eda oral 62 . Por \u00faltimo, KRH-2731 es un nuevo antagonista de CXCR4 de administraci\u00f3n oral. Se une al segundo y tercer bucles extracelulares de CXCR4. Estudios in vitro han concluido que inhibe cepas X4 y R5X4. Su capacidad de inhibici\u00f3n es 10 veces mayor que la de AMD070 63 .",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 129,
                    "text": "44,",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 130,
                    "end": 132,
                    "text": "60",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 1068,
                    "end": 1070,
                    "text": "62",
                    "ref_id": "BIBREF77"
                }
            ],
            "ref_spans": [],
            "section": "F\u00e1rmacos antagonistas de CXCR4"
        },
        {
            "text": "La gp41 es la principal causa del proceso de fusi\u00f3n del VIH a las c\u00e9lulas diana. Si se analiza de forma lineal su estructura, en el extremo N-terminal se encuentra el dominio correspondiente al p\u00e9ptido de fusi\u00f3n. Es su car\u00e1cter hidrof\u00f3bico lo que permite su inserci\u00f3n en la membrana celular. A continuaci\u00f3n se encuentran las regiones repetidas HR1 (heptad-repeat 1) y HR2 (heptad-repeat 2), que presentan amino\u00e1cidos con un patr\u00f3n de repetici\u00f3n caracter\u00edstico de 7 residuos (abcdefg), de los cuales los correspondientes a las posiciones a y d son amino\u00e1cidos hidrof\u00f3bicos. Son ellos los que median la uni\u00f3n de los mon\u00f3meros de gp41 en la forma trim\u00e9rica de la envoltura viral ( fig. 4) . ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 678,
                    "end": 685,
                    "text": "fig. 4)",
                    "ref_id": "FIGREF2"
                }
            ],
            "section": "Fusi\u00f3n del VIH a la c\u00e9lula diana"
        },
        {
            "text": "Durante el proceso de fusi\u00f3n se produce una reorganizaci\u00f3n estructural de gp41 que provoca la interacci\u00f3n entre las regiones HR1 y HR2 y lleva a la formaci\u00f3n de una estructura termoestable de 6 h\u00e9lices (six helix bundle), que es fundamental para que se produzca la fusi\u00f3n entre las membranas del VIH y la c\u00e9lula diana 67 . La estructura de 6 h\u00e9lices est\u00e1 compuesta por un tr\u00edmero interno, formado por las estructuras en espiral enrolladas de HR1, y otro tr\u00edmero externo formado por las regiones HR2. Las regiones HR2 se unen de forma antiparalela a las estructuras en espiral enrollada de HR1 a trav\u00e9s de cavidades hidrof\u00f3bicas 12, 68 . Las interacciones hidrof\u00f3bicas entre las regiones HR1 y HR2 confieren a la estructura de 6 h\u00e9lices una gran estabilidad. El cambio en energ\u00eda libre asociado a la formaci\u00f3n de la estructura de 6 h\u00e9lices es lo que suministra la fuerza necesaria para producir la formaci\u00f3n de un poro de fusi\u00f3n y, en consecuencia, la entrada de la c\u00e1pside viral al interior celular 69 (fig. 6 ). Este modelo de fusi\u00f3n se hab\u00eda descrito previamente para el virus de la gripe, y en fechas m\u00e1s recientes para otros virus como, por ejemplo, Coronavirus causante del s\u00edndrome respiratorio agudo 70, 71 .",
            "cite_spans": [
                {
                    "start": 628,
                    "end": 631,
                    "text": "12,",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 632,
                    "end": 634,
                    "text": "68",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 999,
                    "end": 1001,
                    "text": "69",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 1207,
                    "end": 1210,
                    "text": "70,",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 1211,
                    "end": 1213,
                    "text": "71",
                    "ref_id": "BIBREF87"
                }
            ],
            "ref_spans": [
                {
                    "start": 1002,
                    "end": 1009,
                    "text": "(fig. 6",
                    "ref_id": null
                }
            ],
            "section": "Mecanismo de fusi\u00f3n"
        },
        {
            "text": "Desde principios de la d\u00e9cada de los a\u00f1os noventa se conoce la eficacia antiviral de p\u00e9ptidos sintetizados a partir de la secuencia de amino\u00e1cidos de las regiones HR1 y HR2 de gp41 [72] [73] [74] . El primer p\u00e9ptido inhibidor descrito, DP-106, se sintetiz\u00f3 a partir de la secuencia de amino\u00e1cidos de la regi\u00f3n HR1 de gp41 72 . En 1993 se demostr\u00f3 la potencia in vitro para inhibir la replicaci\u00f3n del VIH de otro p\u00e9ptido, DP-178, en este caso sintetizado a partir de la secuencia de 76 ,77 y frente a virus con mutaciones de resistencia a los inhibidores de la transcriptasa inversa o de la proteasa 8, 9 . Sin embargo, no es activo frente al VIH-2 75, 78 .",
            "cite_spans": [
                {
                    "start": 181,
                    "end": 185,
                    "text": "[72]",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 186,
                    "end": 190,
                    "text": "[73]",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 191,
                    "end": 195,
                    "text": "[74]",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 322,
                    "end": 324,
                    "text": "72",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 482,
                    "end": 484,
                    "text": "76",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 599,
                    "end": 601,
                    "text": "8,",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 602,
                    "end": 603,
                    "text": "9",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 648,
                    "end": 651,
                    "text": "75,",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 652,
                    "end": 654,
                    "text": "78",
                    "ref_id": "BIBREF95"
                }
            ],
            "ref_spans": [],
            "section": "F\u00e1rmacos inhibidores de la fusi\u00f3n"
        },
        {
            "text": "El modelo m\u00e1s aceptado para explicar c\u00f3mo los p\u00e9ptidos dise\u00f1ados sobre la base de las secuencias repetidas HR1 y HR2 de gp41 consiguen una inhibici\u00f3n de la fusi\u00f3n de las membranas viral y celular es el de \u00abinhibici\u00f3n dominante negativo\u00bb 79, 80 . Seg\u00fan este modelo, el modo de acci\u00f3n inhibitorio de la enfuvirtida (que mimetiza a HR2) ser\u00eda por una inhibici\u00f3n competitiva con la regi\u00f3n HR2 de gp41 por la uni\u00f3n a la regi\u00f3n HR1. De esta forma se impedir\u00eda la formaci\u00f3n de la estructura de 6 h\u00e9lices, que es fundamental para que se produzca el poro de fusi\u00f3n. La segunda generaci\u00f3n de inhibidores de fusi\u00f3n est\u00e1 representada por T-1249, que, al igual que la enfuvirtida, es un p\u00e9ptido de 39 amino\u00e1cidos sintetizado sobre la base de la secuencia de HR2 de gp41, aunque en este caso solapa una regi\u00f3n diferente de HR1 66 ( fig. 5 ). Se ha comprobado que T-1249 es activo frente cepas del VIH resistentes a la enfuvirtida y tambi\u00e9n frente al VIH-2 y al virus de la inmunodeficiencia en simios 81, 82 . Sin embargo, el desarrollo cl\u00ednico de este f\u00e1rmaco se interrumpi\u00f3 en enero de 2004.",
            "cite_spans": [
                {
                    "start": 237,
                    "end": 240,
                    "text": "79,",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 241,
                    "end": 243,
                    "text": "80",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 987,
                    "end": 990,
                    "text": "81,",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 991,
                    "end": 993,
                    "text": "82",
                    "ref_id": "BIBREF99"
                }
            ],
            "ref_spans": [
                {
                    "start": 818,
                    "end": 824,
                    "text": "fig. 5",
                    "ref_id": null
                }
            ],
            "section": "Mecanismo de inhibici\u00f3n de gp41"
        },
        {
            "text": "La experiencia en la pr\u00e1ctica cl\u00ednica demuestra que el tratamiento de la infecci\u00f3n por el VIH se enfrenta m\u00e1s pronto o m\u00e1s tarde en la mayor\u00eda de los pacientes con el problema de las resistencias 83 . Por ello, la disponibilidad de una nueva familia de f\u00e1rmacos, como son los inhibidores de la entrada, representa una esperanza para el creciente n\u00famero de pacientes que han fracasado con otros antirretrovirales. La entrada del VIH en la c\u00e9lula se puede bloquear en 3 momentos: a) la uni\u00f3n de gp120 al receptor celular CD4; b) la uni\u00f3n del complejo gp120-CD4 al receptor de quimiocinas (CCR5 o CXCR4), y c) la fusi\u00f3n de las membranas viral y celular. Los f\u00e1rmacos desarrollados para inhibir estas distintas etapas del proceso de entrada presentan diferentes mecanismos de acci\u00f3n y es de esperar que tambi\u00e9n seleccionen distintos mecanismos de resistencia. En el caso de la enfuvirtida, el \u00fanico inhibidor de la entrada comercializado hasta el momento, la resistencia se produce como consecuencia de la selecci\u00f3n de mutaciones en los amino\u00e1cidos que se encuentran entre las posiciones 36 y 45 de la regi\u00f3n HR1 de gp41 (GIVQQQNNLL) [84] [85] [86] (fig. 5 ). Se ha comunicado un amplio abanico de sensibilidad a la enfuvirtida, tanto en pacientes sin tratamiento previo como en individuos con mutaciones de resistencia al f\u00e1rmaco 87, 88 . Los determinantes de esta variabilidad se desconocen, pero parece que polimorfismos en la regi\u00f3n HR2 de gp41 podr\u00edan ser las causas 89 . Hay controversia respecto al efecto del tropismo del VIH por los receptores de quimiocinas CCR5 y CXCR4 y la sensibilidad a la enfuvirtida. Mientras que algunos estudios in vitro han establecido que las cepas del VIH que utilizan CCR5 como correceptor son m\u00e1s resistentes a la enfuvirtida 90, 91 , otros no han encontrado diferencias en la sensibilidad a este f\u00e1rmaco en funci\u00f3n del uso del correceptor 92, 93 .",
            "cite_spans": [
                {
                    "start": 196,
                    "end": 198,
                    "text": "83",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 1130,
                    "end": 1134,
                    "text": "[84]",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 1135,
                    "end": 1139,
                    "text": "[85]",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 1140,
                    "end": 1144,
                    "text": "[86]",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 1327,
                    "end": 1330,
                    "text": "87,",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 1331,
                    "end": 1333,
                    "text": "88",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 1468,
                    "end": 1470,
                    "text": "89",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 1762,
                    "end": 1765,
                    "text": "90,",
                    "ref_id": "BIBREF109"
                },
                {
                    "start": 1766,
                    "end": 1768,
                    "text": "91",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 1876,
                    "end": 1879,
                    "text": "92,",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 1880,
                    "end": 1882,
                    "text": "93",
                    "ref_id": "BIBREF112"
                }
            ],
            "ref_spans": [
                {
                    "start": 1145,
                    "end": 1152,
                    "text": "(fig. 5",
                    "ref_id": null
                }
            ],
            "section": "Resistencia a los inhibidores de la entrada"
        },
        {
            "text": "La familia de los inhibidores de la entrada del VIH marca el comienzo de una nueva era en el tratamiento antirretroviral. La enfuvirtida, que inhibe la fusi\u00f3n del VIH a la c\u00e9lula, es el \u00fanico inhibidor de la entrada aprobado hasta el momento para el tratamiento de la infecci\u00f3n por el VIH. Actualmente se encuentran en fases avanzadas de desarrollo cl\u00ednico otros f\u00e1rmacos que inhiben diferentes etapas del proceso de entrada viral, como la uni\u00f3n de gp120 al receptor celular CD4 o la uni\u00f3n de gp120 a los receptores de quimiocinas CCR5 y CXCR4. Estos nuevos f\u00e1rmacos son activos frente a cepas del VIH que presentan resistencia a los antirretrovirales actuales, de modo que tendr\u00e1n un papel clave en el rescate de pacientes con fracaso terap\u00e9utico.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusiones"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Declining morbidity and mortality among patients with advanced HIV infection. HIV outpatient study investigators",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Pallela",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Delaney",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Moorman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Loveless",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Fuhrer",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Satten",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "N Engl J Med",
            "volume": "338",
            "issn": "",
            "pages": "853--60",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Shafer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Winters",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Palmer",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Merigan",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Ann Intern Med",
            "volume": "128",
            "issn": "",
            "pages": "906--917",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Antiretroviral-drug resistance among patients recently infected with HIV",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Little",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Holte",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Routy",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Daar",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Markowitz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Collier",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "N Engl J Med",
            "volume": "347",
            "issn": "",
            "pages": "385--94",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "HIV entry and its inhibition",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Cell",
            "volume": "93",
            "issn": "",
            "pages": "681--685",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "The plasma membrane as a combat zone in the HIV battlefield",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Doms",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Gen Dev",
            "volume": "14",
            "issn": "",
            "pages": "2677--88",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Endocytic entry of HIV-1",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Fackler",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Peterlin",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Curr Biol",
            "volume": "10",
            "issn": "",
            "pages": "1005--1013",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Immature dendritic cells selectively replicate macrophagetropic (M-tropic) HIV type 1, while mature cells efficiently transmit both M-and T-tropic virus to T cells",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Granelli-Piperno",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Delgado",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Finkel",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Paxton",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Steinman",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Virol",
            "volume": "72",
            "issn": "",
            "pages": "2733--2740",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lazzarin",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Clotet",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cooper",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Reynes",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Arast\u00e9h",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nelson",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "2186--95",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lalezari",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Henry",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "O&apos;hearn",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Montaner",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Piliero",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Trottier",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "2175--85",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hallenberger",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Bosh",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Angliker",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Shaw",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Klenk",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Garten",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Nature",
            "volume": "360",
            "issn": "",
            "pages": "358--61",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "HIV-1 Entry inhibitors",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Dietrich",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "AIDS Rev",
            "volume": "3",
            "issn": "",
            "pages": "89--97",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "HIV-1 gp41: mediator of fusion and target for inhibition",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "AIDS Rev",
            "volume": "5",
            "issn": "",
            "pages": "214--235",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dalgleish",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Beverley",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Clapham",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Crawford",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Greaves",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "Nature",
            "volume": "312",
            "issn": "",
            "pages": "763--770",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Klatzmann",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Champagne",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chamaret",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gruest",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Guetard",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hercend",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "Nature",
            "volume": "312",
            "issn": "",
            "pages": "767--775",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "The CD4 antigen: physiological ligand and HIV receptor",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Sattentau",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "Cell",
            "volume": "52",
            "issn": "",
            "pages": "631--634",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hoxie",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "7",
            "issn": "",
            "pages": "495--504",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant HIV envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Leonard",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Spellman",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Riddle",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Harris",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Gregory",
                    "suffix": ""
                }
            ],
            "year": 1990,
            "venue": "J Biol Chem",
            "volume": "265",
            "issn": "",
            "pages": "10373--82",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Functional regions of the envelope glycoprotein of HIV type 1",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kowalski",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Potz",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Basiripour",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dorfman",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Goh",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Terwilliger",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "Science",
            "volume": "237",
            "issn": "",
            "pages": "1351--1356",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Delineation of a region of the HIV type 1 gp120 glycoprotein critical for interaction with the CD4 receptor",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lasky",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Nakamura",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Fennie",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Shimasaki",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Patzer",
                    "suffix": ""
                }
            ],
            "year": 1987,
            "venue": "Cell",
            "volume": "50",
            "issn": "",
            "pages": "975--85",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Localized changes in the gp120 envelope glycoprotein confer resistance to HIV entry inhibitors BMS-806 and #155",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Madani",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Perdigoto",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Srinivasan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cox",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Chruma",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lalone",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "",
            "pages": "3742--52",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kwong",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wyatt",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sweet",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sodroski",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Hendrickson",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Nature",
            "volume": "393",
            "issn": "",
            "pages": "648--59",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Energetics of the HIV gp120-CD4 binding reaction",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Myszka",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sweet",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Hensley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Brigham-Burke",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kwong",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Hendrickson",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Proc Natl Acad Sci USA",
            "volume": "97",
            "issn": "",
            "pages": "9026--9057",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Allaway",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Davis-Bruno",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Beaudry",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Garc\u00eda",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ryder",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "11",
            "issn": "",
            "pages": "533--542",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Singledose safety, pharmacology and antiviral activity of the HIV type 1 entry inhibitor PRO 542 in HIV-infected adults",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Jacobson",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Lowy",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Fletcher",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "O&apos;neill",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Tran",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ketas",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Infect Dis",
            "volume": "182",
            "issn": "",
            "pages": "326--335",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "The appealing story of HIV entry inhibitors. From discovery of biological mechanisms to drug development",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Castagna",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Biswas",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Beretta",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lazzarin",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Drugs",
            "volume": "65",
            "issn": "",
            "pages": "879--904",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "HIV type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell fusion",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nagashima",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Thompson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rosenfield",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Maddon",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dragic",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Olson",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Infect Dis",
            "volume": "183",
            "issn": "",
            "pages": "1121--1126",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of HIV-1 and HIV infection of CD4+ cells",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Sattentau",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Klasse",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Burkly",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Virol",
            "volume": "66",
            "issn": "",
            "pages": "4784--93",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "The anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Vermeire",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Bell",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chi",
                    "suffix": ""
                },
                {
                    "first": "Jin",
                    "middle": [
                        "Q"
                    ],
                    "last": "Samala",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sodoma",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Mol Pharmacol",
            "volume": "63",
            "issn": "",
            "pages": "203--213",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "CADA inhibits HIV and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Vermeire",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Princen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hatse",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Samala",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dey",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Virology",
            "volume": "302",
            "issn": "",
            "pages": "342--53",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Identification and characterization of a novel inhibitor of HIV-1 entry -I: virology and resistance",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Ricarrdi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Deminie",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Actas de 9th Conference on Retroviruses and Opportunistic Infections",
            "authors": [],
            "year": 2002,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Identification and characterization of a novel inhibitor of HIV-1 entry -II: mechanism of action",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fridell",
                    "suffix": ""
                },
                {
                    "first": "H-T",
                    "middle": [],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Yamanaka",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Colonno",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Actas de 9th Conference on Retroviruses and Opportunistic Infections",
            "authors": [],
            "year": 2002,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Broder",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Berger",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Science",
            "volume": "272",
            "issn": "",
            "pages": "872--879",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Molecular cloning and functional expression of a new human CC-chemokine receptor gene",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Samson",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Labbe",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mollereau",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Vassart",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Parmentier",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Biochemistry",
            "volume": "35",
            "issn": "",
            "pages": "3362--3369",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and HIV type 2 in primary cells",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhan",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Lou",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lal",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gettie",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Marx",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Virol",
            "volume": "74",
            "issn": "",
            "pages": "6893--910",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Connor",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sheridan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Ceradini",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Choe",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Landau",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Exp Med",
            "volume": "185",
            "issn": "",
            "pages": "621--629",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "The crown and stem of the V3 loop play distinct roles in HIV type 1 envelope glycoprotein interactions with the CCR5 coreceptor",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Comier",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dragic",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Virol",
            "volume": "76",
            "issn": "",
            "pages": "8953--8960",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "T-tropic HIV-1-derived V3 loop peptides directly bind to CXCR4 and inhibit T-tropic HIV-1 infection",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sakaida",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hori",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Yonezawa",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sato",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Isaka",
                    "suffix": ""
                },
                {
                    "first": "Yoshie",
                    "middle": [
                        "O"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Virol",
            "volume": "72",
            "issn": "",
            "pages": "9763--70",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Aminoterminal substitutions in the CCR5 coreceptor impair gp120 binding and HIV type 1 entry",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dragic",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Trkola",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Nagashima",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Olson",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Virol",
            "volume": "72",
            "issn": "",
            "pages": "279--85",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Larosa",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kassam",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Heath",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ruffing",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Exp Med",
            "volume": "186",
            "issn": "",
            "pages": "1373--81",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Role of the amino-terminal extracellular domain of CXCR4 in HIV type 1 entry",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Picard",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wilkinson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mcknight",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gray",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hoxie",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Clapham",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Virology",
            "volume": "231",
            "issn": "",
            "pages": "105--116",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-31125 and SCH-350581 inhibit HIV type 1 entry",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Tsamis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gavrilov",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Kajumo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Seibert",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kuhmann",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ketas",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Virol",
            "volume": "77",
            "issn": "",
            "pages": "5201--5209",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "The CCR5 receptorbased mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Watson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jenkinson",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Kazmierski",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kenakin",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Mol Pharmacol",
            "volume": "67",
            "issn": "",
            "pages": "1268--82",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Murakami",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nakajima",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Koyanagi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tachibana",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Fujii",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tamamura",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Exp Med",
            "volume": "186",
            "issn": "",
            "pages": "1389--93",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 coreceptor",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Donzella",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Schols",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Este",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nagashima",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Maddon",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Nature Med",
            "volume": "4",
            "issn": "",
            "pages": "72--79",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Determinants for sensitivity of HIV coreceptor CXCR4 to the bicyclam AMD3100",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Labrosse",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Brelot",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Heveker",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sol",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Schols",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Clercq",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Virol",
            "volume": "72",
            "issn": "",
            "pages": "6381--6389",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Cloning of human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Loetscher",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Geiser",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "O&apos;reilly",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Zwahlen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baggiolini",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Moser",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "J Biol Chem",
            "volume": "269",
            "issn": "",
            "pages": "232--239",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Role of the first and third extracellular domains of CXCR4 in HIV coreceptor activity",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Brelot",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Heveker",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Pleskoff",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Sol",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Alizon",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "J Virol",
            "volume": "71",
            "issn": "",
            "pages": "4744--51",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baba",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Nishimura",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kanzaki",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Okamoto",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sawada",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Iizawa",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Proc Natl Acad Sci USA",
            "volume": "96",
            "issn": "",
            "pages": "5698--703",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Dragic",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Trkola",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Thompson",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Comier",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Kajumo",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Maxwell",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Proc Natl Acad Sci USA",
            "volume": "97",
            "issn": "",
            "pages": "5639--5683",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Anti-HIV-1 activity of TAK-220, a small molecule CCR5 antagonist",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Lizawa",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kanzaki",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Takashima",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Miyake",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tagawa",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Sugihara",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Actas de 10th Conference on Retroviruses and Opportunistic Infections",
            "authors": [],
            "year": 2003,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "10--14",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "RAK-652, a novel small molecule inhibitor of CCR5 antagonist with potent anti-HIV-1 activity",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baba",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kanzaki",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Miyake",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Takashima",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Teshima",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Actas de 12th Conference on Retroviruses and Opportunistic Infections",
            "authors": [],
            "year": 2003,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "10--14",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Potent, broad-spectrum inhibition of HIV type 1 by the CCR5 monoclonal antibody PRO 140",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Trkola",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ketas",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nagashima",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Cilliers",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Virol",
            "volume": "75",
            "issn": "",
            "pages": "579--88",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "The discovery and exploratory development of UK-427,857: a novel CCR5 antagonist for the treatment of HIV",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hitchcock",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Actas de 13th International Symposium on HIV and Emerging Infectious Diseases",
            "authors": [],
            "year": 2004,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "3--5",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "New approaches toward anti-HIV chemotherapy",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Med Chem",
            "volume": "10",
            "issn": "",
            "pages": "241--74",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Evaluation of dosing frequency and food effect on viral load reduction during short-term monotherapy with UK-427",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "F\u00e4tkenheuer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pozniak",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Plettenberg",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Staszewski",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Hoepelman",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "857",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Binding of 2-aryl-4(piperidin-1yl)butanmines and 1, 3, 4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guide mutagenesis study of the binding pocket",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Castonguay",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Weng",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Adolfsen",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Salvo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kilburn",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Caldwell",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Biochemistry",
            "volume": "42",
            "issn": "",
            "pages": "1544--50",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Spirodiketopiperazine-based CCR5 inhibitor, which preserves CC chemokine/CCR5 interactions and exerts potent activity against R5 HIV type 1 in vitro",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Maeda",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Nakata",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Miyakawa",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Gata",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Takaoka",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shibayama",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "",
            "pages": "8654--62",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Potent in vivo anti-R5HIV effects of AK602, a novel spirodiketopiperazine (SPD)-containing HIV-specific CCR5 inhibitor",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Nakata",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Maeda",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kawano",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Miyakawa",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shibayama",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Matsuo",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Actas de 10th Conference on Retroviruses and Opportunistic Infections",
            "authors": [],
            "year": 2003,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "10--14",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Determination of binding sites of a unique CCR5 inhibitor AK602 /ONO-4128/ GW873140 on human CCR5",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Maeda",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ogata",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Harada",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Miyakawa",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Nakata",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Koh",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Actas de 11th Conference on Retroviruses and Opportunistic Infections",
            "authors": [],
            "year": 2004,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "8--11",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "AMD-3100, a CXCR4 antagonist, reduced HIV viral load and X4 virus levels in humans",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Schols",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Claes",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Clercq",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Hendrix",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bridger",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Calandra",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Actas de 9th Conference on Retroviruses and Opportunistic Infections",
            "authors": [],
            "year": 2002,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "24--28",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Anti-HIV activity profile of AMD070, an orally bioavailable CXCR4 antagonist",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Schols",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Claes",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hatse",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Princen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Vermeire",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Clercq",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "Actas de 16th International Conference on Antiviral Research",
            "authors": [],
            "year": 2003,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "A diodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ichiyama",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Yokoyama-Kumakura",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hirose",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bannai",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Proc Natl Acad Sci",
            "volume": "100",
            "issn": "",
            "pages": "4185--90",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "KRH-2731: an orally bioavailable CXCR4 antagonist in vivo",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Murakami",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Yoshida",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kumakura",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mitsuhashi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hirose",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Structure of the leucine zipper",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Albert",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Curr Opin Gen Dev",
            "volume": "2",
            "issn": "",
            "pages": "205--215",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Schulz",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Jameson",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lopalco",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Siccarche",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Weiss",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "8",
            "issn": "",
            "pages": "1571--80",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "Novel therapies based on mechanisms of HIV-1 cell entry",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kilby",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Eron",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "2228--2266",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "A trimeric structural domain of the HIV-1 transmembrane glycoprotein",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Blacklow",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Nature Struct Biol",
            "volume": "2",
            "issn": "",
            "pages": "1075--82",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "The potencial for HIV fusion inhibition",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Cammack",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Curr Opin Infect Dis",
            "volume": "14",
            "issn": "",
            "pages": "13--19",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Mellikan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Markosyan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hemmati",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Delmedico",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lambert",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Cell Biol",
            "volume": "151",
            "issn": "",
            "pages": "413--436",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "A spring-loaded mechanism for the conformational change of influenza hemaglutinin",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Carr",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Cell",
            "volume": "73",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Cloaked similarity between HIV-1 and SARS-CoV suggest an anti-SARS strategy",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kliger",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Levanon",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "BMC Microbiol",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "A synthetic peptide inhibitor of HIV replication: correlation between solution structure and viral inhibition",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wild",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Oas",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Mcdanal",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bolognesi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Matthews",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "Proc Natl Acad Sci",
            "volume": "89",
            "issn": "",
            "pages": "10537--10578",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "Peptides corresponding to a predictive alpha-helical domain of HIV type 1 are potent inhibitors of virus infection",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wild",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Shugars",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Greenwell",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mcdanal",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Matthews",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Proc Natl Acad Sci",
            "volume": "91",
            "issn": "",
            "pages": "9770--9774",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "HIV-1 inhibition by a peptide",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Strik",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Neurath",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Nature",
            "volume": "365",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus mediated cell-cell fusion",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wild",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Greenwell",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Matthews",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "9",
            "issn": "",
            "pages": "1051--1054",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "Are fusion inhibitors active against all HIV variants?",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Poveda",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rod\u00e9s",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Toro",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Soriano",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "20",
            "issn": "",
            "pages": "347--355",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Enfuvirtide is active against HIV-1 type 1 group O",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Poveda",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Barreiro",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rod\u00e9s",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Soriano",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "21",
            "issn": "",
            "pages": "583--588",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Witvrouw",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pannecouque",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Switzer",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Folks",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Clercq",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Heneine",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Antivir Ther",
            "volume": "9",
            "issn": "",
            "pages": "57--65",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wild",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Greenwell",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Shugars",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Rimsky-Clarke",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Matthews",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "11",
            "issn": "",
            "pages": "323--328",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "A molecular clasp in the HIV type 1 TM protein determines the anti-HIV activity of gp41 derivates: implications for viral fusion",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Matthews",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mcdanal",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bolognesi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Greenberg",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Virol",
            "volume": "69",
            "issn": "",
            "pages": "3771--3778",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "T-1249 demonstrates potent antiviral activity over 10-day dosing in most patients who have failed a regimen containing enfuvirtide: planned interim analysis of T1249-102, a phase I/II stydy",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Miralles",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lalezari",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bellos",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Richmond",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Murchison",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Actas de 10 th Conference on Retroviruses and Opportunistic Infections",
            "volume": "",
            "issn": "",
            "pages": "10--14",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "Genotypic and phenotypic evolution of virus envelope through 48 weeks of T-1249 treatment in the T1249-105 study",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Melby",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Cammack",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Greenberg",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Miralles",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "Actas de XIV International HIV Drug Resistance Workshop",
            "authors": [],
            "year": 2005,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "7--11",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "HIV drug resistance",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Clavel",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hance",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "N Engl J Med",
            "volume": "350",
            "issn": "",
            "pages": "1023--1058",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Emergence of resistant HIV type 1 in patients receiving fusion inhibitor (T-20) monotherapy",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Decker",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Arani",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kilby",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Antimicrob Agents Chemother",
            "volume": "46",
            "issn": "",
            "pages": "1896--905",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "Resistance to enfuvirtide, the first HIV fusion inhibitor",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Greenberg",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Cammack",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Antimicrob Chemother",
            "volume": "54",
            "issn": "",
            "pages": "333--373",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Evolution of genotypic and phenotypic resistance to enfuvirtide in HIV-infected patients experiencing prolonged virologic failure",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Poveda",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rod\u00e9s",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Labernardi\u00e8re",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Benito",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Toro",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gonz\u00e1lez-Lahoz",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Med Virol",
            "volume": "74",
            "issn": "",
            "pages": "21--29",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "Baseline susceptibility of primary HIV-1 to entry inhibitors",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Labrosse",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Labernardi\u00e8re",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Dam",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Trouplin",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Skrabal",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Clavel",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Virol",
            "volume": "77",
            "issn": "",
            "pages": "1610--1613",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sista",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Melby",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Davison",
                    "suffix": ""
                },
                {
                    "first": "Jin",
                    "middle": [
                        "L"
                    ],
                    "last": "Mosier",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mink",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "AIDS",
            "volume": "18",
            "issn": "",
            "pages": "1787--94",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Determinants of susceptibility to enfuvirtide map to gp41 in enfuvirtidenaive HIV-1",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Stanfield-Oakley",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Jefrey",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mcdanal",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mosier",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Talton",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Antivir Ther",
            "volume": "8",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "Sensitivity of HIV type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Derdeyn",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Decker",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sfakianos",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "O&apos;brian",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ratner",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Virol",
            "volume": "75",
            "issn": "",
            "pages": "8605--8619",
            "other_ids": {}
        },
        "BIBREF110": {
            "ref_id": "b110",
            "title": "Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Reeves",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gallo",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ahmad",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Miamidian",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Harvey",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sharron",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "99",
            "issn": "",
            "pages": "16249--54",
            "other_ids": {}
        },
        "BIBREF111": {
            "ref_id": "b111",
            "title": "Analysis of baseline enfuvirtide (T-20) susceptibility and co-receptor tropism in two phase III study populations",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Whitcomb",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fransen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Wrin",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Paxinos",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Toma",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Actas de 10 th Conference on Retroviruses and Opportunistic Infections",
            "volume": "",
            "issn": "",
            "pages": "10--14",
            "other_ids": {}
        },
        "BIBREF112": {
            "ref_id": "b112",
            "title": "The relationship between susceptibility to enfuvirtide of baseline viral recombinants and polymorphisms in the env region of R5-tropic HIV-1",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Heilek-Snyder",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Fenger",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ravindran",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tsai",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Cammack",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Esquema lineal de la glucoprote\u00edna gp120 de la envoltura del VIH-1 con las regiones constantes (C1-C5) y variables (V1-V5).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Estructura tridimensional de la glucoprote\u00edna gp120 del VIH.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Esquema de un corte transversal de la estructura de 6 h\u00e9lices de la envoltura del VIH. Est\u00e1 formada por un tr\u00edmero interno de la regi\u00f3n HR1 y un tr\u00edmero externo de la regi\u00f3n HR2. HR1 es rica en leucinas y durante el proceso de fusi\u00f3n adquiere una estructura en espiral enrollada (coilcoiled structure) a trav\u00e9s de la formaci\u00f3n de una cremallera de leucina (leucine zipper). La regi\u00f3n HR2 es rica en tript\u00f3fanos, al igual que el dominio transmembrana situado a continuaci\u00f3n, pr\u00f3ximo al extremo C-terminal de gp41. Las regiones repetidas HR1 y HR2 est\u00e1n separadas por un bucle de 5 amino\u00e1cidos hidrof\u00edlicos definidos por 2 residuos de ciste\u00edna (fig. 5)[64][65][66] .",
            "latex": null,
            "type": "figure"
        },
        "TABREF2": {
            "text": "amino\u00e1cidos de HR2. Esta \u00faltima mol\u00e9cula posteriormente se ha denominado T-20 y enfuvirtida75 . Se trata de un p\u00e9ptido sint\u00e9tico de 36 amino\u00e1cidos que mimetiza la regi\u00f3n HR2 de gp4111,12 (fig. 5) y se ha convertido en el primer inhibidor de la entrada aprobado para el tratamiento de la infecci\u00f3n por el VIH. Es activo frente a diferentes aislados del VIH-1 (grupos M y O)",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}